Selank

Selank is a synthetic heptapeptide with the amino-acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It is derived from a fragment of tuftsin and is studied in neurological research involving neurotransmission, gene expression and GABA-related signalling pathways. Published evidence includes laboratory, animal and limited exploratory human studies, but established clinical evidence remains limited.

Product Features

• Synthetic seven-amino-acid research peptide
• Suitable for controlled laboratory and analytical studies
• Commonly investigated in neurological and neurotransmitter research
• Supplied in securely sealed and clearly labelled packaging
• Intended for handling by qualified research professionals

Research Applications

Selank may be examined in controlled research involving:

• GABA-related receptor signalling
• Neurotransmission and gene-expression responses
• Neurological stress-response pathways
• Cognitive and behavioural research models
• Comparative peptide analysis

Storage

Store according to the conditions stated on the product label or certificate of analysis. Keep the container securely sealed and protected from excessive heat, moisture and direct sunlight.

Important Notice

Selank is not an FDA-approved medicine. The FDA states that compounded products containing Selank acetate may pose immunogenicity risks because of potential aggregation and peptide-related impurities, and that important human safety information is lacking.

This product must not be promoted as a treatment for anxiety, depression, cognitive impairment, sleep disorders or any other medical condition.

For laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.